Skip to main content

Advertisement

SpringerLink
Log in

Multidimensional Treatment of Cancer Pain

  • Palliative Medicine (A Jatoi, Section Editor)
  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Purpose of review

Though numerous treatment options are available to address cancer pain, inadequate management continues to be an ongoing problem worldwide.

Recent findings

A systematic review of the recent scientific literature was conducted with attention to new therapies along with reports of general consensus that were analyzed.

Summary

Pain research continues to be difficult and though numerous guidelines have been developed, adequate powered studies are not common. Good practice would suggest a comprehensive approach to cancer pain management taking into account the many options available and treating each patient with a personalized therapeutic program. Though there is a very low number of randomized control trials, this probably reflects the difficulty in conducting these studies in heterogeneous cancer pain patient populations in sufficient numbers to yield credible study power.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. IASP. 2008–2009 Global Year Against Cancer Pain IASP; 2008 [Available from: https://www.iasp-pain.org/GlobalYear/CancerPain.

  2. •• van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manag. 2016;51(6):1070–90 e9. Not only an excellent review and discussion of cancer pain prevalence but notes progress or lack thereof since previous report in 2007.

    Article  Google Scholar 

  3. Breivik H, Cherny N, Collett B, de Conno F, Filbet M, Foubert AJ, et al. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol. 2009;20(8):1420–33.

    Article  CAS  PubMed  Google Scholar 

  4. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18(9):1437–49.

    Article  PubMed  Google Scholar 

  5. University of Wisconsin-Madison PPS, Group. Opioid Consumption Data 2013 [Available from: http://www.painpolicy.wisc.edu/opioid-consumption-data.]

  6. Delgado-Guay M, Parsons HA, Li Z, Palmer JL, Bruera E. Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer. 2009;17(5):573–9.

    Article  PubMed  Google Scholar 

  7. • Hui D, Bruera E. A personalized approach to assessing and managing pain in patients with cancer. J Clin Oncol. 2014;32(16):1640–6. A very circumspect discussion of individualize pain assessment.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Ripamonti CI, Santini D, Maranzano E, Berti M, Roila F, Group EGW. Management of cancer pain: ESMO clinical practice guidelines. Ann Oncol. 2012;23(Suppl 7):vii139–54.

    Article  PubMed  Google Scholar 

  9. Burton AW, Chai T, Smith LS. Cancer pain assessment. Curr Opin Support Palliat Care. 2014;8(2):112–6.

    Article  PubMed  Google Scholar 

  10. Daeninck P, Gagnon B, Gallagher R, Henderson JD, Shir Y, Zimmermann C, et al. Canadian recommendations for the management of breakthrough cancer pain. Curr Oncol. 2016;23(2):96–108.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Abernethy AP, Wheeler JL, Fortner BV. A health economic model of breakthrough pain. Am J Manag Care. 2008;14(5 Suppl 1):S129–40.

    PubMed  Google Scholar 

  12. • Caraceni A, Davies A, Poulain P, Cortes-Funes H, Panchal SJ, Fanelli G. Guidelines for the management of breakthrough pain in patients with cancer. J Natl Compr Cancer Netw. 2013;11(Suppl 1):S29–36. Recommendations for management of unresolved cancer pain.

    Google Scholar 

  13. Davies A, Zeppetella G, Andersen S, Damkier A, Vejlgaard T, Nauck F, et al. Multi-Centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies. Eur J Pain. 2011;15(7):756–63. Guidelines and discussion of barriers to treatment of break through cancer pain

    Article  PubMed  Google Scholar 

  14. Portenoy RK, Bruns D, Shoemaker B, Shoemaker SA. Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 1: prevalence and characteristics. J Opioid Manag. 2010;6(2):97–108. Discussion of incidence of cancer pain

    Article  PubMed  Google Scholar 

  15. Davies AN, Dickman A, Reid C, Stevens AM, Zeppetella G. Science Committee of the Association for palliative medicine of great B, et al. the management of cancer-related breakthrough pain: recommendations of a task group of the science Committee of the Association for palliative medicine of great Britain and Ireland. Eur J Pain. 2009;13(4):331–8.

    Article  PubMed  Google Scholar 

  16. Hagen NA, Stiles C, Nekolaichuk C, Biondo P, Carlson LE, Fisher K, et al. The Alberta breakthrough pain assessment tool for cancer patients: a validation study using a delphi process and patient think-aloud interviews. J Pain Symptom Manag. 2008;35(2):136–52.

    Article  Google Scholar 

  17. Webber K, Davies AN, Zeppetella G, Cowie MR. Development and validation of the breakthrough pain assessment tool (BAT) in cancer patients. J Pain Symptom Manag. 2014;48(4):619–31.

    Article  Google Scholar 

  18. Sperlinga R, Campagna S, Berruti A, Laciura P, Ginosa I, Paoletti S, et al. Alberta breakthrough pain assessment tool: a validation multicentre study in cancer patients with breakthrough pain. Eur J Pain. 2015;19(7):881–8.

    Article  CAS  PubMed  Google Scholar 

  19. McCracken K. James Logan prize essay. The challenges of cancer pain assessment. Ulster Med J. 2015;84(1):55–7.

    PubMed  PubMed Central  Google Scholar 

  20. Kress HG, Aldington D, Alon E, Coaccioli S, Collett B, Coluzzi F, Huygen G, Jaksch W, Kalso E, Kocot-Kepska M, Mangas AC, Ferri CM, Mavrocordatos P, Morlion B, Muller-Schwefe G, Nicolaou A, Hernandez CP, Sichere P. A holistic approach to chronic pain management that involves all stakeholders: change is needed. Curr Med Res Opin. 2015;31(9):1743–54.

    Article  PubMed  Google Scholar 

  21. Borneman T, Koczywas M, Cristea M, Reckamp K, Sun V, Ferrell B. An interdisciplinary care approach for integration of palliative care in lung cancer. Clin Lung Cancer. 2008;9(6):352–60.

    Article  PubMed  Google Scholar 

  22. Dy SM, Asch SM, Naeim A. Evidence-based standards for cancer pain management. J Clin Oncol. 2008;26:3879–85.

    Article  PubMed  Google Scholar 

  23. Portenoy RK. Treatment of cancer pain. Lancet. 2011;377:2236–47.

    Article  CAS  PubMed  Google Scholar 

  24. Hu C, Zhang H, Wu W, Yu W, Li Y, Bai J, Luo B, Li S. Acupuncture for pain Management in Cancer: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2016;2016:1720239. doi:10.1155/2016/1720239.

    PubMed  PubMed Central  Google Scholar 

  25. Chiu HY, Hsieh YJ, Tsai PS. Systematic review and meta-analysis of acupuncture to reduce cancer-related pain. Eur J Cancer Care (Engl). 2016.

  26. Boyd C, Crawford C, Paat CF, Price A, Xenakis L, Zhang W. The impact of massage therapy on function in pain populations-a systematic review and meta-analysis of randomized controlled trials: part II, cancer pain populations. Evidence for massage therapy (EMT) working group. Pain Med. 2016;17(8):1553–68.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Lee SH, Kim JY, Yeo S, Kim SH, Lim S. Meta-analysis of massage therapy on cancer pain. Integr Cancer Ther. 2015;14(4):297–304. doi:10.1177/1534735415572885.

    Article  PubMed  Google Scholar 

  28. Keenan A, Keithley JK. zer Pain in Adults. Oncol Nurs Forum. 2015;42(6):E368–75.

    Article  PubMed  Google Scholar 

  29. • Lovell MR, Luckett T, Boyle FM, Phillips J, Agar M, Davidson PM. Patient education, coaching, and self-management for cancer pain. J Clin Oncol. 2014;32(16):1712–20. Discussion of education in cancer patients, which is often overlooked.

    Article  PubMed  Google Scholar 

  30. Prevost V, Delorme C, Grach MC, Chvetzoff G, Hureau M. Therapeutic education in improving cancer pain management: a synthesis of available studies. Am J Hosp Palliat Care. 2016;33(6):599–612.

    Article  PubMed  Google Scholar 

  31. Lee YJ, Hyun MK, Jung YJ, Kang MJ, Keam B, Go SJ. Effectiveness of education interventions for the management of cancer pain: a systematic review. Asian Pac J Cancer Prev. 2014;15(12):4787–93.

    Article  PubMed  Google Scholar 

  32. Roditi D, Robinson ME. The role of psychological interventions in the management of patients with chronic pain. Psychol Res Behav Manag. 2011;4:41–9.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Belfer I, Schreiber KL, Shaffer JR, Shnol H, Blaney K, Morando A, et al. Persistent postmastectomy pain in breast cancer survivors: analysis of clinical, demographic, and psychosocial factors. J Pain. 2013;14(10):1185–95.

    Article  PubMed  Google Scholar 

  34. Schreiber KL, Martel MO, Shnol H, Shaffer JR, Greco C, Viray N, et al. Persistent pain in postmastectomy patients: comparison of psychophysical, medical, surgical, and psychosocial characteristics between patients with and without pain. Pain. 2013;154(5):660–8.

    Article  PubMed  Google Scholar 

  35. Zaza C, Baine N. Cancer pain and psychosocial factors: a critical review of the literature. J Pain Symptom Manag. 2002;24(5):526–42.

    Article  Google Scholar 

  36. Gauthier LR, Rodin G, Zimmermann C, Warr D, Librach SL, Moore M, et al. The communal coping model and cancer pain: the roles of catastrophizing and attachment style. J Pain. 2012;13(12):1258–68.

    Article  PubMed  Google Scholar 

  37. Novy DM, Aigner CJ. The biopsychosocial model in cancer pain. Curr Opin Support Palliat Care. 2014;8(2):117–23.

    Article  PubMed  Google Scholar 

  38. Williams ACDC, Eccleston C, Morley S. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database of Systematic Reviews. 2012(11).

  39. Sheinfeld Gorin S, Krebs P, Badr H, Janke EA, Jim HS, Spring B, et al. Meta-analysis of psychosocial interventions to reduce pain in patients with cancer. J Clin Oncol. 2012;30(5):539–47.

    Article  PubMed  Google Scholar 

  40. Gunnarsdottir S, Donovan HS, Serlin RC, Voge C, Ward S. Patient-related barriers to pain management: the barriers questionnaire II (BQ-II). Pain. 2002;99(3):385–96.

    Article  PubMed  Google Scholar 

  41. Miaskowski C, Dodd MJ, West C, Paul SM, Tripathy D, Koo P, et al. Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management. J Clin Oncol. 2001;19(23):4275–9.

    Article  CAS  PubMed  Google Scholar 

  42. Bennett MI, Bagnall AM, Jose CS. How effective are patient-based educational interventions in the management of cancer pain? Systematic review and meta-analysis. Pain. 2009;143(3):192–9.

    Article  PubMed  Google Scholar 

  43. Hassett AL, Gevirtz RN. Nonpharmacologic treatment for fibromyalgia: patient education, cognitive-behavioral therapy, relaxation techniques, and complementary and alternative medicine. Rheum Dis Clin N Am. 2009;35(2):393–407.

    Article  Google Scholar 

  44. Tatrow K, Montgomery GH. Cognitive behavioral therapy techniques for distress and pain in breast cancer patients: a meta-analysis. J Behav Med. 2006;29(1):17–27.

    Article  PubMed  Google Scholar 

  45. • Syrjala KL, Jensen MP, Mendoza ME, Yi JC, Fisher HM, Keefe FJ. Psychological and behavioral approaches to cancer pain management. J Clin Oncol. 2014;32(16):1703–11. A very good review of non-pharmacologic behavioral therapies.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Montgomery GH, Schnur JB, Kravits K. Hypnosis for cancer care: over 200 years young. CA Cancer J Clin. 2013;63(1):31–44.

    Article  PubMed  Google Scholar 

  47. Lang EV, Berbaum KS, Faintuch S, Hatsiopoulou O, Halsey N, Li X, et al. Adjunctive self-hypnotic relaxation for outpatient medical procedures: a prospective randomized trial with women undergoing large core breast biopsy. Pain. 2006;126(1–3):155–64.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Montgomery GH, Weltz CR, Seltz M, Bovbjerg DH. Brief presurgery hypnosis reduces distress and pain in excisional breast biopsy patients. Int J Clin Exp Hypn. 2002;50(1):17–32.

    Article  PubMed  Google Scholar 

  49. Butler LD, Koopman C, Neri E, Giese-Davis J, Palesh O, Thorne-Yocam KA, et al. Effects of supportive-expressive group therapy on pain in women with metastatic breast cancer. Health Psychol. 2009;28(5):579–87.

    Article  PubMed  Google Scholar 

  50. Cramer H, Lauche R, Paul A, Langhorst J, Kummel S, Dobos GJ. Hypnosis in breast cancer care: a systematic review of randomized controlled trials. Integr Cancer Ther. 2015;14(1):5–15.

    Article  PubMed  Google Scholar 

  51. Anderson KO, Cohen MZ, Mendoza TR, Guo H, Harle MT, Cleeland CS. Brief cognitive-behavioral audiotape interventions for cancer-related pain: immediate but not long-term effectiveness. Cancer. 2006;107(1):207–14.

    Article  PubMed  Google Scholar 

  52. •• Cheville AL, Basford JR. The role of rehabilitation medicine and the physical agents in the treatment of cancer-associated pain. J Clin Oncol. 2014;32:1691–702. A comprehensive discussion and review of previous works discussing physiotherapy as well as occupational therapy that can be considered to help both pain and functioning in cancer patients.

    Article  PubMed  Google Scholar 

  53. Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S. Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain. 2001;93(3):247–57.

    Article  CAS  PubMed  Google Scholar 

  54. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F. A validation study of the WHO method for cancer pain relief. Cancer. 1987;59(4):850–6.

    Article  CAS  PubMed  Google Scholar 

  55. Miguel R. Interventional treatment of cancer pain: the fourth step in the World Health Organization analgesic ladder? Cancer Control. 2000;7(2):149–56.

    CAS  PubMed  Google Scholar 

  56. • Vayne-Bossert P, Afsharimani B, Good P, Gray P, Hardy J. Interventional options for the management of refractory cancer pain--what is the evidence? Support Care Cancer. 2016;24(3):1429–38. Another work that notes that there is a dearth of good controlled and adequately powered studies to support many of the interventional procedures commonly employed.

    Article  PubMed  Google Scholar 

  57. Hucker T, Winter N, Chou J. Challenges and advances in pain Management for the Cancer Patient. Curr Anesthesiol Rep. 2015;5:346–53.

    Article  Google Scholar 

  58. Humble SR, Dalton AJ, Li L. A systematic review of therapeutic interventions to reduce acute and chronic post-surgical pain after amputation, thoracotomy or mastectomy. Eur J Pain. 2015;19(4):451–65.

    Article  CAS  PubMed  Google Scholar 

  59. Andreae MH, Andreae DA. Regional anaesthesia to prevent chronic pain after surgery: a Cochrane systematic review and meta-analysis. Br J Anaesth. 2013;111(5):711–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Myers J, Chan V, Jarvis V, Walker-Dilks C. Intraspinal techniques for pain management in cancer patients: a systematic review. Support Care Cancer. 2010;18(2):137–49.

    Article  PubMed  Google Scholar 

  61. Bruera E, Hui D. Spinal analgesia: where is the evidence? Support Care Cancer. 2010;18(10):1237.

    Article  PubMed  Google Scholar 

  62. Pasutharnchat K, Tan K-H, Hadi MA, Ho K-Y. Intrathecal analgesia in patients with cancer pain–an audit in a tertiary. Ann Acad Med Singap. 2009;38:943–6.

    PubMed  Google Scholar 

  63. Bhatnagar S, Gupta M. Evidence-based clinical practice guidelines for interventional pain Management in Cancer Pain. Indian J Palliat Care. 2015;21(2):137–47.

    Article  PubMed  PubMed Central  Google Scholar 

  64. •• WHO’s cancer pain ladder for adults. World Health Organization website. [Available from: http://www.who.int/cancer/palliative/painladder/en/.] The WHO cancer pain recommendations, revised.

  65. Vargas-Schaffer G. Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Physician. 2010;56(6):514–7. e202-5

    PubMed  PubMed Central  Google Scholar 

  66. Ferreira KASL, Kimura M, Teixeira MJ. The WHO analgesic ladder for cancer pain control, twenty years of use: how much pain relief does one get from it? Supp Care Cancer. 2006;14:1086–93.

    Article  Google Scholar 

  67. Burton AW, Hamid B. Current challenges in cancer pain management: does the WHO ladder approach still have relevance? Expert Rev Anticancer Ther. 2007;7(11):1501–2.

    Article  PubMed  Google Scholar 

  68. Paice JA, Von Roenn JH. Under- or overtreatment of pain in the patient with cancer: how to achieve proper balance. J Clin Oncol. 2014;32(16):1721–6. doi:10.1200/JCO.2013.52.5196.

    Article  PubMed  Google Scholar 

  69. Caraceni A, Hanks G, Kaasa S, et al. European palliative care research collaborative (EPCRC); European Association for Palliative Care (EAPC). Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13(2):e58–68.

    Article  CAS  PubMed  Google Scholar 

  70. Bandieri E, Romero M, Ripamonti C, et al. A randomized trial of low-dose morphine versus weak opioids in moderate cancer pain. J Clin Oncol. 2016;34:436–42.

    Article  CAS  PubMed  Google Scholar 

  71. Mantyh P. Bone cancer pain: causes, consequences, and therapeutic opportunities. Pain. 2013;154(Suppl 1):S54–62.

    Article  PubMed  Google Scholar 

  72. Israel FJ, Parker G, Charles M, Reymond L. Lack of benefit from paracetamol (acetaminophen) for palliative cancer patients requiring high-dose strong opioids: a randomized, double-blind, placebo-controlled, crossover trial. J Pain Symptom Manag. 2010;39:548.

    Article  CAS  Google Scholar 

  73. Nabal M, Librada S, Redondo MJ, et al. The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO step III opioids in the control of pain in advanced cancer. A systematic review of the literature Palliat Med. 2012;26:305.

    PubMed  Google Scholar 

  74. Mercadante S, Giarratano A. The long and winding road of non-steroidal antinflammatory drugs and paracetamol in cancer pain management: a critical review. Crit Rev Oncol Hematol. 2013;87(2):140–5.

    Article  PubMed  Google Scholar 

  75. Leppert W, Kowalski G. Long-term administration of high doses of transdermal buprenorphine in cancer patients with severe neuropathic pain. Onco Targets Ther. 2015;8:3621–7.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Pergolizzi JV. Jr1, Mercadante S, Echaburu AV et al. Euromed communications meeting. The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus. Curr Med Res Opin. 2009;25(6):1517–2.

    Article  CAS  PubMed  Google Scholar 

  77. Naing C, Yeoh PN, Aung K. A meta-analysis of efficacy and tolerability of buprenorphine for the relief of cancer pain. Springerplus. 2014;3:87.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Schmidt-Hansen M, Bromham N, Taubert M, Arnold S, Hilgart JS. Buprenorphine for treating cancer pain. Cochrane Database Syst Rev. 2015;31(3):CD009596.

    Google Scholar 

  79. Leppert W. Tramadol as an analgesic for mild to moderate cancer pain. Pharmacol Rep. 2009;61(6):978–92.

    Article  CAS  PubMed  Google Scholar 

  80. Promme E. Tramadol: does it have a role in cancer pain management? J Opioid Manag. 2005;1(3):131–8.

    Google Scholar 

  81. Hartrick CT, Rozek RJ. Tapentadol in pain management: a μ-opioid receptor agonist and noradrenaline reuptake inhibitor. CNS Drugs. 2011;25(5):359–70.

    Article  CAS  PubMed  Google Scholar 

  82. Raffa RB, Buschmann H, Christoph T, Eichenbaum W, et al. Mechanistic and functional differentiation of tapentadol and tramadol. Expert Opin Pharmacother. July 2012;13(10):1437–49.

    Article  CAS  PubMed  Google Scholar 

  83. Wiffen PJ, Derry S, Naessens K, Bell RF. Oral tapentadol for cancer pain. Cochrane Database Syst Rev. 2015;25(9):CD011460.

    Google Scholar 

  84. Coluzzi F, Raffa RB, Pergolizzi J, et al. Tapentadol prolonged release for patients with multiple myeloma suffering from moderate-to-severe cancer pain due to bone disease. J Pain Res. 2015;8:229–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Rosario M, Francesco R, Sergio F et al. Effectiveness of tapentadol prolonged release for the management of painful mucositis in head and neck cancers during intensity modulated radiation therapy. Support Care Cancer. 2016

  86. • Crews KR, Gaedigk A, Dunnenberger HM, et al. Clinical pharmacogenetics implementation consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update. Clin Pharmacol Ther. 2014;95(4):376–82. Recent discussion of how genetics influences the marked individual variable response to codeine. Also applicable to other opioids.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Bell GC, Donovan KA, McLeod HL. Clinical implications of opioid pharmacogenomics in patients with cancer. Cancer Control. 2015;22(4):426–32.

    PubMed  Google Scholar 

  88. Barton MK. First-line low-dose morphine is better for the control of moderate cancer pain than weaker opioids. CA Cancer J Clin. 2016;66(3):177–8.

    Article  PubMed  Google Scholar 

  89. Bandieri E, Romero M, Ripamonti CI, Artioli F, Sichetti D, Fanizza C, Santini D, Cavanna L, Melotti B, Conte PF, Roila F, Cascinu S, Bruera E, Tognoni G, Luppi M. Randomized trial of low-dose morphine versus weak opioids in moderate cancer pain. J Clin Oncol. 2016;34(5):436–42.

    Article  CAS  PubMed  Google Scholar 

  90. Corli O, Floriani I, Roberto A, Montanari M, Galli F, Greco MT, et al. Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicentre randomized phase IV 'real life' trial on the variability of response to opioids. Ann Oncol. 2016;27(6):1107–15.

    Article  CAS  PubMed  Google Scholar 

  91. Schmidt-Hansen M, Bennett MI, Hilgart J. Oxycodone for cancer pain in adult patients. JAMA. 2015;314(12):1282–3.

    Article  CAS  PubMed  Google Scholar 

  92. Holzer P, Ahmedzai SH, Niederle N, Leyendecker P, Hopp M, Bosse B, Spohr I, Reimer K. Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management. J Opioid Manag. 2009;5(3):145–51.

    PubMed  Google Scholar 

  93. Mercadante S, Giarratano A. Combined oral prolonged-release oxycodone and naloxone in chronic pain management. Expert Opin Investig Drugs. 2013;22(1):161–6.

    Article  CAS  PubMed  Google Scholar 

  94. Krashin D, Murinova N, Trescot AM. Extended-release hydrocodone - gift or curse? J Pain Res. 2013;6:53–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  95. Clemens KE, Likar R. Versatility of different pharmaceutical formulations of hydromorphone in the management of severe cancer pain and pain in palliative care. Pain Manag. 2013;3(5):369–75. doi:10.2217/pmt.13.26.

    Article  PubMed  Google Scholar 

  96. Chwieduk CM, McKeage K. Fentanyl sublingual: in breakthrough pain in opioid-tolerant adults with cancer. Drugs. 2010;70(17):2281–8.

    Article  CAS  PubMed  Google Scholar 

  97. Blick SK, Wagstaff AJ. Fentanyl buccal tablet: in breakthrough pain in opioid-tolerant patients with cancer. Drugs. 2006;66(18):2387–93. discussion 2394-5

    Article  CAS  PubMed  Google Scholar 

  98. Watts P, Smith A. PecSys: in situ gelling system for optimised nasal drug delivery. Expert Opin Drug Deliv. 2009;6(5):543–52.

    Article  CAS  PubMed  Google Scholar 

  99. Porta-Sales J, Garzón-Rodríguez C, Villavicencio-Chávez C, Llorens-Torromé S, González-Barboteo J. Efficacy and safety of methadone as a second-line opioid for cancer pain in an outpatient clinic: a prospective open-label study. Oncologist. 2016;21(8):981–7.

    Article  PubMed  Google Scholar 

  100. •• Glare PA, Davies PS, Finlay E, Gulati A, Lemanne D, Moryl N, Oeffinger KC, Paice JA, Stubblefield MD, Syrjala KL. Pain in cancer survivors. J Clin Oncol. 2014;32:1739–47. Good discussion and review of issues and treatment of cancer survivors.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pain Management Centre, Department of Anaesthesiology, Singapore General Hospital, Outram Road, Singapore, 169608, Singapore

    Weiyang Christopher Liu, Kian Hian Tan & Gregory J. Meredith

  2. Ministry of Health Holdings Pte Ltd, 1 Maritime Square, #11-25 Harbour Front Centre, Singapore, 099253, Singapore

    Zhong Xi Zheng

Authors
  1. Weiyang Christopher Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhong Xi Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kian Hian Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gregory J. Meredith
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gregory J. Meredith.

Ethics declarations

Conflict of Interest

Weiyang Christopher Liu, Zhong Xi Zheng, Kian Hian Tan, and Gregory J. Meredith declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Palliative Medicine

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, W.C., Zheng, Z.X., Tan, K.H. et al. Multidimensional Treatment of Cancer Pain. Curr Oncol Rep 19, 10 (2017). https://doi.org/10.1007/s11912-017-0570-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11912-017-0570-0

Keywords

Search

Navigation